NSUP
WST icon

NLB Skladi upravljanje premozenja’s West Pharmaceutical WST Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Sell
9,500
-986
-9% -$301K 0.13% 130
2026
Q1 		$2.63M Buy
10,486
+6,486
+162% +$1.61M 0.13% 133
2025
Q4 		$1.1M Buy
+4,000
New +$1.09M 0.05% 216

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NLB Skladi upravljanje premozenja's WST Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja reduced its West Pharmaceutical (WST) stake by 9.4% in Q2 2026, selling an estimated $301K and leaving 9,500 shares worth $3.41M. The position accounts for 0.13% of the portfolio, ranked #130.

NLB Skladi upravljanje premozenja first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 9,500 shares of West Pharmaceutical worth $3.41M as of Q2 2026.
  • NLB Skladi upravljanje premozenja sold 986 West Pharmaceutical shares in Q2 2026, an estimated $301K.
  • West Pharmaceutical made up 0.13% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #130 holding.
  • NLB Skladi upravljanje premozenja first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.